Lateral Wedge Insoles With and Without Contoured Arch Support for People With Knee Osteoarthritis and Foot Pain: A Pilot, Feasibility Randomized Controlled Trial.

J Foot Ankle ResSep 1, 2026

Michael A Hunt, Natasha M Krowchuk, Haocheng Zhang et al.

✦ AI-curated · Sources linked

In 30 seconds

This pilot randomized controlled trial evaluated the feasibility and effects of lateral wedge insoles (LWIs) in 30 individuals with knee osteoarthritis and foot pain over 12 weeks. The study found that LWIs were safe and well-tolerated, with participants reporting moderate comfort levels. Trends indicated improvements in knee pain and function, as well as knee adduction moments.

Key findings

  • Participants reported moderate comfort with insoles, scoring 7/10.
  • 83% of participants met the 30-minute daily wear time threshold.
  • Trends showed improvement in knee pain and function in both groups.
  • No major adverse events were reported during the study.

Why it matters

Understanding the effects of lateral wedge insoles on knee osteoarthritis and foot pain can help clinicians consider non-surgical treatment options that may improve patient outcomes and comfort.

Source

Published in J Foot Ankle Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Orthopedic Surgery

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.